Entropy Technologies LP Makes New $5.59 Million Investment in Danaher Corporation $DHR

Entropy Technologies LP acquired a new stake in shares of Danaher Corporation (NYSE:DHRFree Report) in the 1st quarter, Holdings Channel.com reports. The fund acquired 29,470 shares of the conglomerate’s stock, valued at approximately $5,588,000.

Other hedge funds have also recently modified their holdings of the company. Main Street Group LTD bought a new position in shares of Danaher in the 1st quarter worth about $25,000. JPL Wealth Management LLC bought a new stake in Danaher during the third quarter worth about $25,000. Elevated Capital Advisors LLC bought a new stake in Danaher during the fourth quarter worth about $26,000. WFA of San Diego LLC purchased a new stake in Danaher in the second quarter worth about $26,000. Finally, Hilton Head Capital Partners LLC purchased a new stake in Danaher in the fourth quarter worth about $27,000. Institutional investors own 79.05% of the company’s stock.

Danaher Stock Down 0.3%

DHR stock opened at $191.87 on Friday. The stock has a market capitalization of $134.88 billion, a P/E ratio of 34.08, a P/E/G ratio of 2.38 and a beta of 0.79. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.65 and a quick ratio of 1.52. Danaher Corporation has a 1-year low of $160.93 and a 1-year high of $242.80. The business has a fifty day moving average price of $185.64 and a 200-day moving average price of $197.04.

Danaher (NYSE:DHRGet Free Report) last released its quarterly earnings data on Tuesday, July 21st. The conglomerate reported $1.94 EPS for the quarter, beating the consensus estimate of $1.85 by $0.09. Danaher had a return on equity of 11.04% and a net margin of 15.95%.The company had revenue of $6.26 billion for the quarter, compared to analysts’ expectations of $6.12 billion. During the same period last year, the firm posted $0.77 earnings per share. Danaher’s revenue was up 5.5% compared to the same quarter last year. Equities analysts forecast that Danaher Corporation will post 8.53 earnings per share for the current fiscal year.

Danaher Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Friday, June 26th will be issued a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.8%. The ex-dividend date of this dividend is Friday, June 26th. Danaher’s dividend payout ratio (DPR) is presently 28.42%.

Trending Headlines about Danaher

Here are the key news stories impacting Danaher this week:

Wall Street Analysts Forecast Growth

Several research firms have recently issued reports on DHR. Wells Fargo & Company lowered their target price on shares of Danaher from $212.00 to $195.00 and set an “equal weight” rating for the company in a report on Wednesday. Evercore restated an “outperform” rating and issued a $230.00 price target on shares of Danaher in a research note on Monday, July 6th. DZ Bank initiated coverage on Danaher in a research report on Wednesday, June 3rd. They set a “buy” rating and a $210.00 price objective for the company. Morgan Stanley lowered their price objective on Danaher from $270.00 to $255.00 and set an “overweight” rating for the company in a research note on Wednesday, April 22nd. Finally, Guggenheim dropped their target price on Danaher from $235.00 to $200.00 and set a “buy” rating on the stock in a report on Wednesday. One equities research analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and five have assigned a Hold rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $228.91.

Get Our Latest Stock Analysis on DHR

About Danaher

(Free Report)

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.

See Also

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHRFree Report).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.